Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share Price (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,463.00    7.00 (0.48%)
Bid:
1,468.00
Ask:
1,469.00
Spread: 1.00 (0.068%)
Market Cap: £3.10b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals Share Price
Price 1,463.00 Open 1,470.00
Bid 1,468.00 High 1,471.00
Ask 1,469.00 Low 1,451.00
Change 7.00 (0.48%) Close 1,456.00
Volume 558,780
Currency GBX
Issue Country GB
Shares in Issue 212.02m
Market Cap £3.10b
PE Ratio 10.825
EPS 135.15011
Year High 2,146.00
Year High Date 12-Jun-2025
Year Low 1,187.00
Year Low Date 09-Mar-2026
Dividend 63.62268
Yield 4.349%
# Trades 1,696
Vol. Sold 151,907
Sold Value £2.04m
Vol. Bought 400,366
Bought Value £5.79m
Market Size 500
What if I invested £1,000 in Hikma Pharmaceuticals?
£ 1,032.10 (+3.21%)
1 month ago
£ 1,222.22 (+22.22%)
3 months ago
£ 956.21 (-4.38%)
6 months ago
£ 698.00 (-30.20%)
1 year ago
Add HIK to WatchlistAdd HIK to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Hikma Pharmaceuticals Plc Ord Shs 10p

Hikma Pharmaceuticals is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 350, FTSE 100 indices.

Hikma Pharmaceuticals is listed in the Medicine and Biotech sector.

Hikma Pharmaceuticals Plc Ord Shs 10p is listed on the London Stock Exchange trading with ticker code HIK.L. It has a market capitalisation of £3.10b, with approximately 212.02m shares in issue. Over the last year, Hikma Pharmaceuticals share price has been traded in a range of 959.00, hitting a high of 2,146.00, and a low of 1,187.00.

Hikma Pharmaceuticals PLC is a leading British multinational pharmaceutical company founded in 1978. With a global presence, Hikma specialises in the development, manufacturing, and marketing of a wide range of generic and branded pharmaceutical products. The company operates in various therapeutic areas, including injectables, oral liquids, and tablets. Hikma Pharmaceuticals is committed to improving global health outcomes by providing affordable and high-quality medications. Through its robust research and development capabilities, strong partnerships, and global distribution network, Hikma Pharmaceuticals PLC plays a crucial role in delivering accessible healthcare solutions to patients worldwide.

Some Videos You Might Like

What's Hot in a heatwave


 

What's Hot in FTSE Reshuffl...


What's Hot in a heatwave


Recent Share Trades for Hikma Pharmaceuticals (HIK)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
10-Jun-2615:27:551,462.0019Unknown*1,468.001,469.00277.78O Ordinary
Delayed publication
Was reported as OTC
10-Jun-2617:11:351,461.7251,500Unknown*1,468.001,469.0021.93kO Ordinary
Was reported as OTC
10-Jun-2616:47:071,459.9533,855Buy*1,468.001,469.0056.28kO Ordinary
10-Jun-2616:35:231,463.008,894Buy*1,468.001,469.00130.12kO Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.00150Buy*1,468.001,469.002,195O Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.007Buy*1,468.001,469.00102.41O Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.00119Buy*1,468.001,469.001,741O Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.00147Buy*1,468.001,469.002,151O Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.00682Buy*1,468.001,469.009,978O Ordinary
Trade was executed as an SI
10-Jun-2616:35:231,463.00758Buy*1,468.001,469.0011.09kO Ordinary
Trade was executed as an SI

Directors Deals for Hikma Pharmaceuticals (HIK)

Announced Traded Action Notifier Price Currency Amount Holding
02-Jun-2601-Jun-26Transfer FromMazen Darwazah held the position of Executive Vice Chairman at the time of this trade.Mazen Darwazah0.0093,4133,149,568
02-Jun-2601-Jun-26Transfer FromSaid Darwazah held the position of CEO at the time of this trade.Said Darwazah0.00111,57314,856,091
28-Apr-2627-Apr-26BuyVictoria Hull held the position of Chairman at the time of this trade.Victoria Hull1,376.00GBX03,214
11-Nov-2507-Nov-25BuySaid Darwazah held the position of Executive Chairman at the time of this trade.Said Darwazah1,541.00GBX70,00014,744,518
11-Nov-2507-Nov-25BuySaid Darwazah held the position of Executive Chairman at the time of this trade.Said Darwazah1,589.00GBX60,00014,744,518
Hikma Pharmaceuticals

Hikma is a global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.

Hikma Pharmaceuticals Home Page